![Quiver Logo](/static/img/logo-icon.png)
![EVOK logo](https://quiver-logos.s3.us-east-2.amazonaws.com/evok.png)
Evoke Pharma, Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view EVOK Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of EVOK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EVOK's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to EVOK
Recent picks made for EVOK stock on CNBC
ETFs with the largest estimated holdings in EVOK
Flights by private jets registered to EVOK
![Quiver Logo](/static/img/logo-icon.png)